Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo.

miR-135a contributes to paclitaxel resistance in tumor cells both in vitro and in vivo. Oncogene. 2011 Oct 27; 30(43):4386-98.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.